Clinicians are advising gradual dose increases and close follow-up, especially for people with diabetes or a history of eye disease
Tirzepatide, the active drug behind it, acts on the same receptors as semaglutide
Repeatedly injecting into the same spot can lead to lipohypertrophy a condition where fatty lumps develop under the skin due to localised tissue trauma
1) suggests a pressing need for more advanced cartilage repair technologies that might obviate the need for TKA and control the high socio-economic burden of end-stage knee arthritis
However, if you experience any discomfort or side effects that could impact your ability to concentrate or operate machinery, consult your doctor immediately
Not for human consumption, diagnostic use, or veterinary use